系统层面的转变,以增加患者参与临床试验
Nicole E Caston1,2, Luqin Deng3, Courtney P Williams3
1Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), Birmingham, AL.
JCO oncology practice
|March 13, 2025
概括
癌症临床试验的修改被乳腺癌幸存者认为是有利的. 然而,来自社会脆弱地区的参与者表现出不太愿意参与修改后的试验协议,这表明需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 由于COVID-19大流行,美国食品和药物管理局 (FDA) 允许对癌症临床试验进行修改.
- 政策制定者正在评估这些试验修改的延续.
- 了解患者对这些变化的影响的看法对于未来的政策决策至关重要.
研究的目的:
- 评估乳腺癌幸存者在COVID-19大流行期间对癌症临床试验的修改的观点.
- 调查县级社会脆弱性与参与修改后临床试验的意愿之间的联系.
主要方法:
- 一项横截面研究调查了573名女性乳腺癌幸存者.
- 根据试验修改 (位置,远程医疗,方便性,选择退出程序) 收集关于参与意愿的数据.
- 使用社会脆弱性指数 (SVI) 评估了县级的社会脆弱性;多项逻辑回归分析了协会.
主要成果:
- 超过一半的参与者 (53%) 非常愿意参加在家药物递送的试验.
- 在最脆弱的县 (前10%SVI) 的受访者没有表现出参与远程医疗试验的意愿 (OR,0.21 [95%CI,0.07到0.63]).
- 对于脆弱人群中的其他试验修改也观察到类似的非显著趋势.
结论:
- 乳腺癌幸存者通常对癌症临床试验的修改做出了有利的反应.
- 居住在高度社会脆弱的县的个人受到这些修改的影响较小.
- 需要进行进一步的研究,以确定可以增强弱势患者群体参与试验的修改.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K


